Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3978)
All Articles published online
|
Dec 7, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Malaguarnera M, Pistone G, Elvira R, Leotta C, Scarpello L, Liborio R. Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 2005; 11(45): 7197-7202 [PMID: 16437672 DOI: 10.3748/wjg.v11.i45.7197] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i45/7197.htm |
| Number | Citing Articles |
| 1 |
Maryam Alimirah, Omar Sadiq, Stuart C. Gordon. Novel Therapies in Hepatic Encephalopathy. Clinics in Liver Disease 2020; 24(2): 303 doi: 10.1016/j.cld.2020.01.009
|
| 2 |
Michele Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Valentina Colonna, Masa Messano, Aleardo Koverech, Sergio Neri, Marco Vacante, Lisa Cammalleri, Massimo Motta. Acetyl l-carnitine (ALC) treatment in elderly patients with fatigue. Archives of Gerontology and Geriatrics 2008; 46(2): 181 doi: 10.1016/j.archger.2007.03.012
|
| 3 |
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
|
| 4 |
Mariano Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Marco Vacante, Corrado Risino, Lisa Cammalleri, Giovanni Pennisi, Liborio Rampello. Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy. Digestive Diseases and Sciences 2008; 53(11): 3018 doi: 10.1007/s10620-008-0238-6
|
| 5 |
Tanja Burkard, Annette Biedermann, Christoph Herold, Michael Dietlein, Markus Rauch, Martin Diefenbach. Treatment with a potassium–iron–phosphate–citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2013; 25(3): 352 doi: 10.1097/MEG.0b013e32835afaa5
|
| 6 |
Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, Koji Uchino, Ryo Nakagomi, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, Yuichiro Eguchi, Tatsuya Kanto, Shoji Kubo, Hitoshi Yoshiji, Hiroaki Miyata, Namiki Izumi, Masatoshi Kudo, Kazuhiko Koike. Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). Journal of Gastroenterology 2022; 57(8): 587 doi: 10.1007/s00535-022-01893-5
|
| 7 |
Michele Malaguarnera, Marco Vacante, Massimo Motta, Maria Giordano, Giulia Malaguarnera, Rita Bella, Giuseppe Nunnari, Liborio Rampello, Giovanni Pennisi. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metabolic Brain Disease 2011; 26(4): 281 doi: 10.1007/s11011-011-9260-z
|
| 8 |
Yevgeniya I. Shurubor, Alexander E. Rogozhin, Elena P. Isakova, Yulia I. Deryabina, Boris F. Krasnikov. Tricarboxylic Acid Metabolite Imbalance in Rats with Acute Thioacetamide-Induced Hepatic Encephalopathy Indicates Incomplete Recovery. International Journal of Molecular Sciences 2023; 24(2): 1384 doi: 10.3390/ijms24021384
|
| 9 |
N. M. BASS. Review article: the current pharmacological therapies for hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 2007; 25(s1): 23 doi: 10.1111/j.1746-6342.2006.03218.x
|
| 10 |
Yasuhiro Takikawa, Hidekatsu Kuroda, Kei Sawara. The Liver in Systemic Diseases. 2016; : 51 doi: 10.1007/978-4-431-55790-6_4
|
| 11 |
Non-absorbable disaccharides and antibacterials are the treatment of choice for hepatic encephalopathy. Drugs & Therapy Perspectives 2011; 27(6): 17 doi: 10.2165/11206630-000000000-00000
|
| 12 |
Makoto Shiraki, Masahito Shimizu, Hisataka Moriwaki, Kiwamu Okita, Kazuhiko Koike. Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients. Hepatology Research 2017; 47(4): 321 doi: 10.1111/hepr.12750
|
| 13 |
|
| 14 |
|
| 15 |
Ting Wang, Kazuyuki Suzuki, Keisuke Kakisaka, Mio Onodera, Kei Sawara, Yasuhiro Takikawa. L‐carnitine prevents ammonia‐induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytes. Journal of Gastroenterology and Hepatology 2019; 34(7): 1249 doi: 10.1111/jgh.14497
|
| 16 |
Chathur Acharya, Jasmohan S. Bajaj. Current Management of Hepatic Encephalopathy. American Journal of Gastroenterology 2018; 113(11): 1600 doi: 10.1038/s41395-018-0179-4
|
| 17 |
Longfa Kou, Rui Sun, Vadivel Ganapathy, Qing Yao, Ruijie Chen. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5). Expert Opinion on Therapeutic Targets 2018; 22(8): 715 doi: 10.1080/14728222.2018.1502273
|
| 18 |
Mariano Malaguarnera, Giovanni Pistone, Marinella Astuto, Ignazio Vecchio, Rocco Raffaele, Emilia Lo Giudice, Liborio Rampello. Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled Trial. Digestive Diseases and Sciences 2006; 51(12): 2242 doi: 10.1007/s10620-006-9187-0
|
| 19 |
Aleksey Tadevosyan, Joshua Kornbluth. Brain Herniation and Intracranial Hypertension. Neurologic Clinics 2021; 39(2): 293 doi: 10.1016/j.ncl.2021.02.005
|
| 20 |
Hisamitsu Miyaaki, Hironori Kobayashi, Satoshi Miuma, Masanori Fukusima, Ryu Sasaki, Masafumi Haraguchi, Kazuhiko Nakao. Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01190-6
|
| 21 |
Thomas Bøhmer, Anne Bøen, Siv Cathrine Høymork. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine. Scandinavian Journal of Gastroenterology 2010; 45(6): 762 doi: 10.3109/00365521003624169
|
| 22 |
Yuka Hayakawa, Nobuharu Tamaki, Hiroyuki Nakanishi, Masayuki Kurosaki, Yuki Tanaka, Kento Inada, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Ryuichi Okamoto, Namiki Izumi. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal Medicine 2023; 62(7): 973 doi: 10.2169/internalmedicine.0212-22
|
| 23 |
Joji Tani, Asahiro Morishita, Teppei Sakamoto, Kei Takuma, Mai Nakahara, Koji Fujita, Kyoko Oura, Tomoko Tadokoro, Shima Mimura, Takako Nomura, Hirohito Yoneyama, Hideki Kobara, Takashi Himoto, Tsutomu Masaki. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2021; 32(2): 288 doi: 10.1097/MEG.0000000000001748
|
| 24 |
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Kouichi Gondo, Yu Asano, Nobuhiro Hattori, Nobuharu Tamaki, Shoko Suzuki, Yutaka Yasui, Takanori Hosokawa, Jun Itakura, Yuka Takahashi, Namiki Izumi. L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 2015; 13(8): 1540 doi: 10.1016/j.cgh.2014.12.005
|
| 25 |
Yudai Fujiwara, Kazuyuki Suzuki, Kenji Yusa, Makoto Eizuka, Manami Miura, Yuki Watanabe, Hiroshi Takahashi, Yasuhiro Takikawa. Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy. Internal Medicine 2021; 60(7): 1027 doi: 10.2169/internalmedicine.5793-20
|
| 26 |
Ravindra Arya, Sheffali Gulati, Satish Deopujari. Management of hepatic encephalopathy in children. Postgraduate Medical Journal 2010; 86(1011): 34 doi: 10.1136/pgmj.2009.079467
|
| 27 |
Nicolas Weiss, Pierre Barbier Saint Hilaire, Benoit Colsch, Foucauld Isnard, Suleiman Attala, Augustin Schaefer, Maria del Mar Amador, Marika Rudler, Foudil Lamari, Frédéric Sedel, Dominique Thabut, Christophe Junot. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. Journal of Hepatology 2016; 65(6): 1120 doi: 10.1016/j.jhep.2016.07.046
|
| 28 |
Sarah Yun, Ciana Scalia, Sara Farghaly. Treatment of Hyperammonemia Syndrome in Lung Transplant Recipients. Journal of Clinical Medicine 2023; 12(22): 6975 doi: 10.3390/jcm12226975
|
| 29 |
Zdravka Zafirova, Michael O'Connor. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure. Current Opinion in Anaesthesiology 2010; 23(2): 121 doi: 10.1097/ACO.0b013e32833724c3
|
| 30 |
Qian Jiang, Gang Jiang, Ke-qing Shi, Hong Cai, Yi-xin Wang, Ming-hua Zheng. Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine. Annals of Hepatology 2013; 12(5): 803 doi: 10.1016/S1665-2681(19)31323-7
|
| 31 |
Kazuyuki Suzuki, Mio Onodera, Keisuke Kakisaka, Kei Endo, Kei Sawara, Kanta Oikawa, Ting Wang, Ryujin Endo, Yasuhiro Takikawa. Serum free fatty acid concentration as a surrogate marker for serum carnitine status in patients with liver cirrhosis. Kanzo 2013; 54(11): 796 doi: 10.2957/kanzo.54.796
|
| 32 |
Reza Heidari. Natural Molecules in Neuroprotection and Neurotoxicity. 2024; : 957 doi: 10.1016/B978-0-443-23763-8.00075-0
|
| 33 |
Yevgeniya I. Shurubor, Alexander E. Rogozhin, Elena P. Isakova, Yulia I. Deryabina, Boris F. Krasnikov. Residual Amino Acid Imbalance in Rats during Recovery from Acute Thioacetamide-Induced Hepatic Encephalopathy Indicates Incomplete Healing. International Journal of Molecular Sciences 2023; 24(4): 3647 doi: 10.3390/ijms24043647
|
| 34 |
Mariano Malaguarnera, Rita Bella, Marco Vacante, Maria Giordano, Giulia Malaguarnera, Maria Pia Gargante, Massimo Motta, Antonio Mistretta, Liborio Rampello, Giovanni Pennisi. Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2011; 46(6): 750 doi: 10.3109/00365521.2011.565067
|
| 35 |
Shunsuke Tsubata, Kohei Ogawa, Masaaki Hirano, Akira Sakamaki, Yukio Aruga, Masashi Yamakawa. Experience using levocarnitine chloride in treatment of hepatic encephalopathy. Kanzo 2014; 55(1): 76 doi: 10.2957/kanzo.55.76
|
| 36 |
Marsha Y. Morgan, A. Blei, K. Grüngreiff, R. Jalan, G. Kircheis, G. Marchesini, O. Riggio, Karin Weissenborn. The treatment of hepatic encephalopathy. Metabolic Brain Disease 2007; 22(3-4): 389 doi: 10.1007/s11011-007-9060-7
|
| 37 |
Eric Monnet, Lisa Klopp, Angela J. Marolf, Eric Monnet, Craig B. Webb, Ronald Bright, Daniel D. Smeak. Small Animal Soft Tissue Surgery. 2012; : 407 doi: 10.1002/9781118997505.ch43
|
| 38 |
Roger F. Butterworth. Alcohol and the Nervous System. Handbook of Clinical Neurology 2014; 125: 589 doi: 10.1016/B978-0-444-62619-6.00034-3
|
| 39 |
Miroslav Cuturic, Ruth K. Abramson, Robert R. Moran, James W. Hardin, Elaine M. Frank, Andrea A. Sellers. Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patients. Neurological Sciences 2013; 34(1): 93 doi: 10.1007/s10072-012-0952-x
|
| 40 |
Michele Malaguarnera, Marco Vacante, Maria Giordano, Giovanni Pennisi, Rita Bella, Liborio Rampello, Mariano Malaguarnera, Giovanni Li Volti, Fabio Galvano. Oral acetyl-l-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. The American Journal of Clinical Nutrition 2011; 93(4): 799 doi: 10.3945/ajcn.110.007393
|
| 41 |
Eugeniy S. Protasov, Daria V. Borsakova, Yuliya G. Alexandrovich, Anatoliy V. Korotkov, Elena A. Kosenko, Andrey A. Butylin, Fazoil I. Ataullakhanov, Elena I. Sinauridze. Erythrocytes as bioreactors to decrease excess ammonium concentration in blood. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37828-5
|
| 42 |
Bojana Marković-Živković, Goran Bjelaković, Danica Marković, Dušica Stojanović. NUTRITIVNA TERAPIJA HEPATIČNE ENCEFALOPATIJE KAO KOMPLIKACIJE CIROZE JETRE. Acta medica medianae 2013; : 39 doi: 10.5633/amm.2012.0208s
|
| 43 |
Akram Jamshidzadeh, Hossein Niknahad, Reza Heidari, Mahdi Zarei, Mohammad Mehdi Ommati, Forouzan Khodaei. Carnosine protects brain mitochondria under hyperammonemic conditions: Relevance to hepatic encephalopathy treatment. PharmaNutrition 2017; 5(2): 58 doi: 10.1016/j.phanu.2017.02.004
|
| 44 |
Lisa Klopp, Angela J. Marolf, Eric Monnet, Craig B. Webb. Small Animal Soft Tissue Surgery. 2023; : 133 doi: 10.1002/9781119693741.ch13
|
| 45 |
Peter Ferenci, Christian Müller. Evidence‐Based Gastroenterology and Hepatology. 2010; : 636 doi: 10.1002/9781444314403.ch39
|
| 46 |
Tatsunori Hanai, Makoto Shiraki, Kenji Imai, Atsushi Suetugu, Koji Takai, Masahito Shimizu. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis. Nutrients 2020; 12(7): 1915 doi: 10.3390/nu12071915
|
| 47 |
Kazumichi Abe, Masashi Fujita, Manabu Hayashi, Atsushi Takahashi, Hiromasa Ohira. The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy. Internal Medicine 2021; 60(22): 3533 doi: 10.2169/internalmedicine.7175-21
|
| 48 |
Yasuhiro Takikawa, Takuro Sato, Keisuke Kakisaka. The Evolving Landscape of Liver Cirrhosis Management. 2019; : 93 doi: 10.1007/978-981-13-7979-6_8
|
| 49 |
Yan‐Yan Jia, Cheng‐Tao Lu, Juan Feng, Ying Song, Jin‐Yi Zhao, Shan Wang, Yuan Sun, Ai‐Dong Wen, Zhi‐Fu Yang, Tai‐Jun Hang. Impact on L‐carnitine Homeostasis of Short‐term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil. Basic & Clinical Pharmacology & Toxicology 2013; 113(6): 431 doi: 10.1111/bcpt.12112
|
| 50 |
Nader Dbouk, Brendan M. McGuire. Hepatic encephalopathy: A review of its pathophysiology and treatment. Current Treatment Options in Gastroenterology 2006; 9(6): 464 doi: 10.1007/s11938-006-0003-x
|
| 51 |
A. Hagerman, O. Karam. Molecular Adsorbent Recirculating System (MARS™ en réanimation pédiatrique. Réanimation 2016; 25(2): 239 doi: 10.1007/s13546-015-1162-3
|
| 52 |
Sahar Hosseini, Alireza Ebrahimi, Fereshteh Bagheri, Yasaman Emami, Elmira Esmaeilzadeh, Negar Azarpira, Sedigheh Ebrahimi, Soheil Ashkani-Esfahani. Effect of Resveratrol on Thioacetamide-induced Liver Damage in Rat Models. Hepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.103902
|
| 53 |
Zakraus K. Mahdavi, Ram Narayan, Shraddha Mainali, Benjamin M. Greenberg, Venkatesh Aiyagari, David L. McDonagh. A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement Use. Neurocritical Care 2018; 29(3): 504 doi: 10.1007/s12028-017-0473-9
|
| 54 |
Na Li, Hui Zhao. Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.689042
|
| 55 |
Kazuto TAJIRI, Yuka FUTSUKAICHI, Saito KOBAYASHI, Satoshi YASUMURA, Terumi TAKAHARA, Masami MINEMURA, Toshiro SUGIYAMA. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis. Journal of Nutritional Science and Vitaminology 2018; 64(5): 321 doi: 10.3177/jnsv.64.321
|
| 56 |
Berkeley N. Limketkai, Stephen D. Zucker. Hyperammonemic Encephalopathy Caused by Carnitine Deficiency. Journal of General Internal Medicine 2008; 23(2): 210 doi: 10.1007/s11606-007-0473-0
|
| 57 |
Arturo J Martí-Carvajal, Christian Gluud, Ingrid Arevalo-Rodriguez. Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2014; doi: 10.1002/14651858.CD011451
|
| 58 |
Khanyisani Ziqubu, Phiwayinkosi V. Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje. Brown adipose tissue-derived metabolites and their role in regulating metabolism. Metabolism 2024; 150: 155709 doi: 10.1016/j.metabol.2023.155709
|
| 59 |
Marsha Y. Morgan. Sherlock's Diseases of the Liver and Biliary System. 2011; : 121 doi: 10.1002/9781444341294.ch8
|
| 60 |
Na Xu, Shicui Zhang. Identification, expression and bioactivity of a chitotriosidase-like homolog in amphioxus: Dependence of enzymatic and antifungal activities on the chitin-binding domain. Molecular Immunology 2012; 51(1): 57 doi: 10.1016/j.molimm.2012.02.003
|
| 61 |
Hwayoung Lee, Hyung-Ki Kim, Jun-Tack Kwon, Shohyun Park, Hae Jeong Park, Su Kang Kim, Jin Kyung Park, Won Sub Kang, Young Jong Kim, Joo-Ho Chung, Jong Woo Kim, Hak-Jae Kim. BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophrenia. Psychiatry Research 2018; 259: 197 doi: 10.1016/j.psychres.2017.10.018
|
| 62 |
Mariano Malaguarnera, Corrado Risino, Lisa Cammalleri, Lucia Malaguarnera, Marinella Astuto, Ignazio Vecchio, Liborio Rampello. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study. European Journal of Gastroenterology & Hepatology 2009; 21(7): 762 doi: 10.1097/MEG.0b013e328309c791
|
| 63 |
C F Rose. Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy. Clinical Pharmacology & Therapeutics 2012; 92(3): 321 doi: 10.1038/clpt.2012.112
|
| 64 |
Piero Amodio. Cirrhosis: A practical guide to management. 2015; : 105 doi: 10.1002/9781118412640.ch11
|
| 65 |
Piero Amodio. Hepatic encephalopathy: Diagnosis and management. Liver International 2018; 38(6): 966 doi: 10.1111/liv.13752
|
| 66 |
Michael Bismuth, Natalie Funakoshi, Jean-François Cadranel, Pierre Blanc. Hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2011; 23(1): 8 doi: 10.1097/MEG.0b013e3283417567
|
| 67 |
Raja Ganesan, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Dong Joon Kim, Ki Tae Suk. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease. Life Sciences 2023; 322: 121626 doi: 10.1016/j.lfs.2023.121626
|
| 68 |
Naoto Fujiwara, Hayato Nakagawa, Kenichiro Enooku, Yotaro Kudo, Yuki Hayata, Takuma Nakatsuka, Yasuo Tanaka, Ryosuke Tateishi, Yohko Hikiba, Kento Misumi, Mariko Tanaka, Akimasa Hayashi, Junji Shibahara, Masashi Fukayama, Junichi Arita, Kiyoshi Hasegawa, Hadassa Hirschfield, Yujin Hoshida, Yoshihiro Hirata, Motoyuki Otsuka, Keisuke Tateishi, Kazuhiko Koike. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 2018; 67(8): 1493 doi: 10.1136/gutjnl-2017-315193
|
| 69 |
Paula V. Phongsamran, Jiwon W. Kim, Jennifer Cupo Abbott, Angela Rosenblatt. Pharmacotherapy for Hepatic Encephalopathy. Drugs 2010; 70(9): 1131 doi: 10.2165/10898630-000000000-00000
|
| 70 |
Nathan J. Shores, Emmet B. Keeffe. Is Oral l-Acyl-Carnitine an Effective Therapy for Hepatic Encephalopathy? Review of the Literature. Digestive Diseases and Sciences 2008; 53(9): 2330 doi: 10.1007/s10620-007-0183-9
|
| 71 |
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clinical and Molecular Hepatology 2020; 26(2): 83 doi: 10.3350/cmh.2019.0010n
|
| 72 |
Hiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, Masayuki Kurosaki, Leona Osawa, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Mao Okada, Wang Wan, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Yutaka Yasui, Takamasa Noda, Kaoru Nakanishi, Kaoru Tsuchiya, Jun Itakura, Yuka Takahashi, Namiki Izumi. Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70585-y
|
| 73 |
Vinay Sundaram, Obaid S. Shaikh. Hepatic Encephalopathy: Pathophysiology and Emerging Therapies. Medical Clinics of North America 2009; 93(4): 819 doi: 10.1016/j.mcna.2009.03.009
|
| 74 |
Amir Abbasnezhad, Razieh Choghakhori, Sara Kashkooli, Meysam Alipour, Omid Asbaghi, Rasool Mohammadi. Effect of L‐carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2019; 34(12): 2062 doi: 10.1111/jgh.14765
|
| 75 |
Dragana Savic, Leanne Hodson, Stefan Neubauer, Michael Pavlides. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2020; 12(8): 2178 doi: 10.3390/nu12082178
|